T. Watson

发表

The Use of Glycidyl Ethers Involving Aziridinium Intermediates and Other Methodology for the Preparation of Enantiomerically Pure Drug Candidates

Timothy J. N. Watson, T. A. Ayers, T. Watson, 2012 .

Synthesis of the kappa-agonist CJ-15,161 via a palladium-catalyzed cross-coupling reaction.

Arun K. Ghosh, S. Caron, T. Watson, 2002, Chemical communications.

Synthesis of (1‐(Aminomethyl)‐2,3‐dihydro‐1H‐inden‐3‐yl)methanol: Structural Confirmation of the Main Band Impurity Found in Varenicline® Starting Material

M. McMahon, T. Watson, R. Singer, 2008 .

Alternative Synthesis of Septic Shock Candidate 3,4-Dihydro-3,3-dimethylisoquinoline N-Oxide (MDL 101002) Utilizing an Improved Pictet−Spengler Reaction

T. Watson, 1998 .

Chemical Development of MDL 103371: An N-Methyl-d-Aspartate-Type Glycine Receptor Antagonist for the Treatment of Stroke†

B. Harrison, R. A. Farr, E. Huber, 2000 .

Asymmetric catalysis in the pharmaceutical industry.

Timothy J. N. Watson, J. Hawkins, T. Watson, 2004, Angewandte Chemie.

IS through-bond dihydroaromaticity attainable ? preparation of [4,5]dihomotropone, investigation of its ground-state properties, and an attempt to generate the dihomotropylium cation

D. Friedrich, L. Paquette, R. Bishop, 1994 .

Utilization of the Phenylthio Substituent as a Multipurpose Synthetic Tool. Direct Application to the Enantioselective Construction of (-)-Salsolene Oxide.

D. Friedrich, L. Paquette, T. Watson, 1997, The Journal of organic chemistry.

BRIDGEHEAD OXIRANYL SESQUITERPENOIDS. ASYMMETRIC TOTAL SYNTHESIS OF (-)-SALSOLENE OXIDE

D. Friedrich, L. Paquette, T. Watson, 1997 .

A novel, efficient and general synthetic route to unsymmetrical triphenylene mesogens using palladium-catalysed cross-coupling reactions

Timothy J. N. Watson, J. Goodby, M. Hird, 1994 .

Process Research and Scale-up of the κ-Opioid Receptor Agonist CJ-15,161 Drug Candidate

Nga M. Do, Arun K. Ghosh, S. Caron, 2006 .

Synthesis and properties of [4,5]dihomotropone (bicyclo[5.1.1]Nona-2,5-dien-4-one)

Timothy J. N. Watson, R. Bishop, E. Bacqué, 1992 .

API Quality by Design Example from the Torcetrapib Manufacturing Process

Roger Nosal, Jason Mustakis, Timothy J. N. Watson, 2007, Journal of Pharmaceutical Innovation.

The Application of Science- and Risk-Based Concepts to Drug Substance Stability Strategies

Roger Nosal, Stephen T. Colgan, Timothy J. Watson, 2012, Journal of Pharmaceutical Innovation.

Establishing Patient Centric Specifications for Drug Substance and Drug Product Impurities

Timothy J. N. Watson, J. Berridge, S. M. Tyler, 2018, Journal of Pharmaceutical Innovation.

The Selection and Control of Starting Materials Should be Governed by Science and Risk-Based Approaches

Roger Nosal, Timothy J. N. Watson, Frank Montgomery, 2016, The AAPS Journal.